Influenza virus circulation and vaccine effectiveness during June 2021-May 2023 in Thailand.
Case-control studies
Influenza
Influenza vaccines
Respiratory tract diseases
Sentinel surveillance
Vaccine effectiveness
Journal
Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
received:
20
10
2023
revised:
23
05
2024
accepted:
24
06
2024
medline:
24
7
2024
pubmed:
24
7
2024
entrez:
24
7
2024
Statut:
epublish
Résumé
Thai Ministry of Public Health recommends influenza vaccination for certain risk groups. We evaluated 2023 Southern Hemisphere influenza vaccine effectiveness against medically attended influenza using surveillance data from nine Thai hospitals and a test-negative design. During June 2022-May 2023, influenza vaccine provided moderate protection against seeking care for influenza illness (adjusted vaccine effectiveness 51%; 95% confidence interval 28-67). Understanding vaccine effectiveness can help guide future antigen selection and support clinicians to make a strong influenza vaccine recommendation to patients.
Identifiants
pubmed: 39044732
doi: 10.1016/j.jvacx.2024.100517
pii: S2590-1362(24)00090-1
pmc: PMC11263786
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100517Informations de copyright
© 2024 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.